We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LMTL:NASDAQDirexion Daily LMT Bull 2X ETF Analysis

Data as of 2026-04-15 - not real-time

$45.67

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

LMTL currently trades at $45.67, sitting below its 20‑day (47.62) and 50‑day (50.46) SMAs while still above the 200‑day SMA (36.98), indicating short‑term weakness within a broadly neutral longer‑term context. RSI at 42.7 and a bearish MACD histogram (‑0.10) reinforce the near‑term downside bias, and volume has been trending lower, suggesting waning buying pressure. Yet the ETF posted a robust YTD gain of ~50% and the market sentiment gauge reads “Extreme Greed” (88.6), highlighting strong bullish momentum in the underlying names.
The fund’s 2× exposure to high‑profile catalysts such as Adobe (ADBE), PayPal (PYPL), Texas Instruments (TXN) and UnitedHealth (UNH) — underscored in recent launch news — fuels its performance but also concentrates risk in a handful of sectors. Leveraged structure, a 1.07% expense ratio, and a 30‑day volatility of nearly 49% amplify potential swings, while the recent drawdown of ‑27.8% flags downside vulnerability. Given a beta of 0.47, the ETF moves less than the broader market, yet its daily reset nature makes it unsuitable for long‑term hold.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 20‑day and 50‑day SMAs indicating short‑term weakness
  • Bearish MACD and decreasing volume signal fading momentum
  • High 30‑day volatility (~49%) increases downside risk

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Strong YTD return (~50%) driven by leveraged exposure to momentum stocks
  • Extreme Greed sentiment (FGI 88.6) supports continued upside
  • Low beta (0.47) suggests moderated market‑wide swings

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Leveraged daily reset leads to decay over extended horizons
  • High expense ratio (1.07%) erodes long‑term returns
  • Concentrated exposure to a few high‑beta equities increases sector risk

Key Metrics & Analysis

Fund Metrics

Expense Ratio1.07%
AUM$9.0M
Inception Date2025-08-05
Avg Daily Volume13,050
Premium/Discount0.00%
Tracking Error0.00%

Technical Analysis

TrendNeutral
RSI42.7
Support$43.39
Resistance$51.49
MA 20$47.62
MA 50$50.46
MA 200$36.98
MACDBearish
VolumeDecreasing
Fear & Greed Index88.64

Risk Assessment

Beta0.47
Volatility48.82%
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.